<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Acta biomedica scientifica</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Acta biomedica scientifica</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Acta biomedica scientifica</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2541-9420</issn>
   <issn publication-format="online">2587-9596</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">14236</article-id>
   <article-id pub-id-type="doi">10.12737/23030</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>обзоры</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>Review</subject>
    </subj-group>
    <subj-group>
     <subject>обзоры</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">POSTCONDITIONING AS A METHOD TISSUE SURVIVABILITY ENHANCEMENT IN ISCHEMIC DAMAGE</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>ПОСТКОНДИЦИОНИРОВАНИЕ КАК МЕТОД ПОВЫШЕНИЯ ВЫЖИВАЕМОСТИ ТКАНЕЙ ПРИ ИШЕМИЧЕСКОМ ПОВРЕЖДЕНИИ</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Шурыгин</surname>
       <given-names>Михаил Геннадьевич</given-names>
      </name>
      <name xml:lang="en">
       <surname>Shurygin</surname>
       <given-names>Mikhail Gennadievich</given-names>
      </name>
     </name-alternatives>
     <email>mshurygin@gmail.com</email>
     <bio xml:lang="ru">
      <p>доктор медицинских наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>doctor of medical sciences;</p>
     </bio>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Шурыгина</surname>
       <given-names>Ирина Александровна</given-names>
      </name>
      <name xml:lang="en">
       <surname>Shurygina</surname>
       <given-names>Irina Aleksandrovna</given-names>
      </name>
     </name-alternatives>
     <email>irinashurygina@gmail.com</email>
     <bio xml:lang="ru">
      <p>доктор медицинских наук;</p>
     </bio>
     <bio xml:lang="en">
      <p>doctor of medical sciences;</p>
     </bio>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Дремина </surname>
       <given-names>Наталья  Николаевна</given-names>
      </name>
      <name xml:lang="en">
       <surname>Dremina </surname>
       <given-names>Natalya  Николаевна</given-names>
      </name>
     </name-alternatives>
     <email>drema76@mail.ru</email>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Иркутский научный центр хирургии и травматологии</institution>
     <city>Иркутск</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Irkutsk Scientific Center of Surgery and Traumatology</institution>
     <city>Irkutsk</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Иркутский научный центр хирургии и травматологии</institution>
     <city>Иркутск</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Irkutsk Scientific Center of Surgery and Traumatology</institution>
     <city>Irkutsk</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2016-12-03T00:00:00+03:00">
    <day>03</day>
    <month>12</month>
    <year>2016</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2016-12-03T00:00:00+03:00">
    <day>03</day>
    <month>12</month>
    <year>2016</year>
   </pub-date>
   <volume>1</volume>
   <issue>4</issue>
   <fpage>183</fpage>
   <lpage>186</lpage>
   <self-uri xlink:href="https://naukaru.ru/en/nauka/article/14236/view">https://naukaru.ru/en/nauka/article/14236/view</self-uri>
   <abstract xml:lang="ru">
    <p>В настоящее время изучение механизмов посткондиционирования находится на начальном этапе. Перспективы клинического применения посткондиционирования выглядят достаточно оптимистично. Связано это с тем, что применение различных вариантов прекондиционирования ограничено из-за невозможности в большинстве случаев предугадать время развития ишемического повреждения, а посткондиционирование может быть использовано для уменьшения негативных последствий после наступления продолжительной ишемии.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>The article presents the present-day data on the phenomenon of ischemic myocardial postconditioning. It has been shown, that this phenomenon consists in protection of the heart from reperfusion damage by the means of short episodes of ischemia/reperfusion performed at the early stage after prolonged ischemia. It is presented that postconditioning effect manifests in limiting the size of infarction and preserving endothelial function in the region exposed to ischemic injury. The article reports on the modern concept of role of various intracellular signal cascades in providing survival of the cell after the episode of ischemia/reperfusion. Much attention is given to changing in the state of pores localized in internal mitochondrial membrane as end links of realization of postconditioning effect. Prospects of clinical use of postconditioning are very optimistic due to the fact that application of different variants of preconditioning is limited because in most cases it is impossible to predict the time of occurrence of ischemic injury, whereas postconditioning may be used after prolonged ischemia.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>посткондиционирование</kwd>
    <kwd>ишемия</kwd>
    <kwd>инфаркт</kwd>
    <kwd>сигнальные каскады</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>postconditioning</kwd>
    <kwd>ischemia</kwd>
    <kwd>myocardial infarction</kwd>
    <kwd>signal cascade</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">БарсукевичВ.Ч., БасалайМ.В., МрочекА.Г., Бул-гакА.Г., ЧаснойтьА.Р. Участие RISK- и SAFE-путей в механизмах развития кардиопротекторного эффекта позднего ишемического посткондиционирования // Кардиология в Беларуси. - 2012. - No4. - С.34-46.</mixed-citation>
     <mixed-citation xml:lang="en">BarsukevichVC, BasalayMV, MrochekAG, BulgakAG, ChasnoytAR (2012). Participation of RISK- and SAFE-ways in the mechanisms of cardioprotective effect of late ischemic postconditioning [Uchastie RISK- i SAFE-putey v mekhanizmakh razvitiya kardioprotektornogo effekta pozdnego ishemicheskogo postkonditsionirovaniya]. Kardiologiya v Belarusi, (4), 34-46.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ДреминаН.Н., ШурыгинМ.Г., ШурыгинаИ.А. Изменение микроциркуляторного компонента ми-окарда под воздействием фактора роста эндотелия сосудов в постинфарктный период // Бюл. ВСНЦ СО РАМН. - 2008. - No4. - С.73-75.</mixed-citation>
     <mixed-citation xml:lang="en">Dremina NN, Shurygin MG, Shurygina IA (2008). Myocardium microcirculation component change influenced by vessels endothelium growth factor during postinfarction period [Izmenenie mikrotsirkulyatornogo komponenta miokarda pod vozdeystviem faktora rosta endoteliya sosudov v postinfarktnyy period]. Bulleten’ Vostocno-Sibirskogo naucnogo centra, (4), 73-75.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ДреминаН.Н., ШурыгинаИ.А., ЛушниковаЕ.Л., НепомнящихЛ.М. Влияние эндотелиального фактора роста на постинфарктное ремоделирование миокарда крыс // Бюллетень экспериментальной биологии и медицины. - 2009. - Т.148, No9. - С.330-336.</mixed-citation>
     <mixed-citation xml:lang="en">DreminaNN, ShuryginaIA, LushnikovaEL,NepomnyashchikhLM (2009). Effect of endothelial growth factor on postinfarction remodeling of rat myocardium [Vliyanie endotelial’nogo faktora rosta na postinfarktnoe remodelirovanie miokarda krys]. Byulleten’ eksperimental’noy biologii i meditsiny, 148 (3), 441-446</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ЛебединскийВ.Ю., ШурыгинМ.Г., ДудкинВ.В. Внутримиокардиальное давление (природа, способы измерения и регистрации) Методические рекоменда-ции. - Иркутск: Реаниматор, 1991. - 76с.</mixed-citation>
     <mixed-citation xml:lang="en">LebedinskyVY, ShuryginMG, DudkinVV (1991). Intramyocardial pressure (nature, methods of measurement and registration): Guidelines [Vnutrimiokardial’noe davlenie (priroda, sposoby izmereniya i registratsii) Metodicheskie rekomendatsii], 76</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">МасловЛ.Н., МрочекА.Г., ХалиулинИ.Г., Ха-нушЛ.,     ПейЖ.М., ЖангИ. Адаптивный феномен ишемического посткондиционирования сердца. Перспективы клинического применения // Вестник Российской академии медицинских наук. - 2013. - No1. - С.10-20.</mixed-citation>
     <mixed-citation xml:lang="en">MaslovLN, MrochekAG, KhaliulinI, KhanushL, PeyJ  M, ZhangY (2013). Adaptive phenomenon of ischemic postconditioning of the heart. Perspectives of clinical use [Adaptivnyy fenomen ishemicheskogo postkonditsionirovaniya serdtsa. Perspektivy klinicheskogo primeneniya]. Vestnik Rossiyskoy akademii meditsinskikh nauk, (1), 10-20.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">МасловЛ.Н., МрочекА.Г., ЩепёткинИ.А., ХедрикД.П., ХанушЛ., БарзахЕ.И., ЛишмановА.Ю., ГорбуновА.С., ЦибульниковС.Ю., БайковА.Н. Роль протеинкиназ в формировании адаптивного фено-мена ишемического посткондиционирования сердца //Р  оссийский физиологический журнал им. И.М.Се-ченова. - 2013. - Т.99, No4. - С.433-452.</mixed-citation>
     <mixed-citation xml:lang="en">MaslovL    N, MrochekAG, Shchepiotkin IA, Khedrik DP, KhanushL, BarzakhEI, LishmanovAY, GorbunovAS, TsybulnikovSY, BaykovAN (2013). Role of protein kinases in development of adaptive phenomenon of heart ischemic postconditioning [Rol’ proteinkinaz v formirovanii adaptivnogo fenomena ishemicheskogo postkonditsionirovaniya serdtsa]. Rossiyskiy fiziologicheskiy zhurnal im. I.M. Sechenova, 99 (4), 433-452.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">НепомнящихЛ.М., ЛушниковаЕ.Л., Ларио-новП.М.,     ШурыгинМ.Г. Регенерация миокарда: проли-феративный потенциал кардиомиоцитов и индукция кардиомиогенеза при альтеративной и пластической недостаточности сердца // Вестник Российской академии медицинских наук. - 2010. - No5. - С.3-11.</mixed-citation>
     <mixed-citation xml:lang="en">NepomnyashchikhLM, LushnikovaEL, LarionovPM, ShuryginMG (2010). Myocardial regeneration: proliferative potential of cardiomyocytes and induction of cardiomyogenesis at alterative and plastic cardiac failure [Regeneratsiya miokarda: proliferativnyy potentsial kardiomiotsitov i induktsiya kardiomiogeneza pri al’terativnoy i plasticheskoy nedostatochnosti serdtsa]. Vestnik Rossiyskoy akademii meditsinskikh nauk, (5), 3-11</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШляхтоЕ.В., НифонтовЕ.М., ГалагудзаМ.М. Пре- и посткондиционирование как способы кардио-цитопротекции: патофизиологические и клинические аспекты // Сердечная недостаточность. - 2008. - Т.9, No1. - С.4-10.</mixed-citation>
     <mixed-citation xml:lang="en">ShlyakhtoEV, NifontovEM, GalagudzaMM (2008). Pre- and postconditioning as methods of cardioprotection: pathophysiological and clinical aspects [Pre- i postkonditsionirovanie kak sposoby kardiotsitoprotektsii: patofiziologicheskie i klinicheskie aspekty]. Serdechnaya nedostatochnost’, 9 (1), 4-10.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШурыгинМ.Г., ДреминаН.Н., ШурыгинаИ.А., МачхинИ.Н. Основные активаторы ангиогенеза и их применение в кардиологии (обзор литературы) // Бюл. ВСНЦ СО РАМН. - 2005. - No6. - С.199-207.</mixed-citation>
     <mixed-citation xml:lang="en">ShuriginMG, DreminaNN, ShuriginaIA, MachkhinIN(2005). Main activators of angiogenesis and their use in cardiology (review) [Osnovnye aktivatory angiogeneza i ikh primenenie v kardiologii (obzor literatury)]. Bulleten’ Vostocno-Sibirskogo naucnogo centra, (6), 199-207.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШурыгинМ.Г., МалышевВ.В., ДреминаН.Н. Закономерности ремоделирования миокарда при постинфарктном кардиосклерозе. - Иркутск, 2007. - 196с.</mixed-citation>
     <mixed-citation xml:lang="en">ShuryginMG, MalyshevVV, DreminaNN (2007). Laws of myocardial remodeling with postinfarction cardiosclerosis [Zakonomernosti remodelirovaniya miokarda pri postinfarktnom kardioskleroze], 196.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШурыгинМ.Г., ШурыгинаИ.А. Фактор роста фи-бробластов как стимулятор ангиогенеза при инфаркте миокарда // Бюл. СО РАМН. - 2010. - Т.30, No6. - С.89-92.</mixed-citation>
     <mixed-citation xml:lang="en">ShuriginMG, ShuriginaIA (2010). Fibroblast growth factor as angiogenesis stimulator at myocardial infarction [Faktor rosta fibroblastov kak stimulyator angiogeneza pri infarkte miokarda]. Bul. SO RAMN, 30 (6), 89-92.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШурыгинМ.Г., ШурыгинаИ.А., ДреминаН.Н. Влияние основного фибробластического фактора роста на выраженность цитолиза при эксперимен-тальном инфаркте миокарда // Бюл. ВСНЦ СО РАМН.-2008. - No6. - С.58-60.</mixed-citation>
     <mixed-citation xml:lang="en">ShuryginMG, ShuryginaIA, DreminaNN (2008). In-fluence of basic fibroblast growth factor on the cytolytic syndrome at experimental myocardial infarction [Vliyanie osnovnogo fibroblasticheskogo faktora rosta na vyrazhen-nost’ tsitoliza pri eksperimental’nom infarkte miokarda]. Bulleten  ’ Vostocno  -Sibirskogo naucnogo centra, (6), 58-60.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШурыгинМ.Г., ШурыгинаИ.А., ДреминаH.H. Влияние фактора роста эндотелия сосудов на выра-женность цитолиза при экспериментальном инфар-кте миокарда // Бюл. ВСНЦ СО РАМН. - 2008. - Т.59, No1. - С.68-71.</mixed-citation>
     <mixed-citation xml:lang="en">ShuryginMG, ShuryginaIA, DreminaNN (2008). Influ-ence of vessels endothelium growth factor on the cytolysis intensity at experimental cardiac infarction [Vliyanie fak-tora rosta endoteliya sosudov na vyrazhennost’ tsitoliza pri eksperimental’nom infarkte miokarda]. Bulleten’ Vostocno-Sibirskogo naucnogo centra, 59 (1), 68-71.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШурыгинМ.Г., ШурыгинаИ.А., ДреминаН.Н. Динамика факторов роста эндотелия сосудов и фи-бробластического фактора роста при эксперимен-тальном инфаркте миокарда // Бюл. ВСНЦ СО РАМН. - 2007. - No6. - С.169-174.</mixed-citation>
     <mixed-citation xml:lang="en">ShuriginMG, ShuriginaIA, DreminaNN (2007). Dy-namics of vasoendothelial growth factor and fibro-blast growth factor in experimental cardiac infarction [Dinamika faktorov rosta endoteliya sosudov i fibroblasticheskogo fak-tora rosta pri eksperimental’nom infarkte miokarda]. Bul-leten’   Vostocno  -Sibirskogo naucnogo centra,    (6), 169-174</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШурыгинМ.Г., ШурыгинаИ.А., ДреминаН.Н., КаняО.В. Ангиогенез как адаптивный механизм при ишемии // Бюл. ВСНЦ СО РАМН. - 2013. - No5(93). - С.192-195.</mixed-citation>
     <mixed-citation xml:lang="en">ShuryginMG, ShuryginaIA, DreminaNN, KanyaOV (2013). Angiogenesis as an adaptive mechanism in ischemia [Angiogenez kak adaptivnyy mekhanizm pri ishemii]. Bul-leten’ Vostocno-Sibirskogo naucnogo centra, (5), 192-195.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШурыгинМ.Г., ШурыгинаИ.А., ДреминаН.Н., КаняО.В. Прекондиционирование как защита от ише-мического повреждения миокарда // Бюл. ВСНЦ СО РАМН. - 2013. - No2-2(90). - С.206-210.</mixed-citation>
     <mixed-citation xml:lang="en">ShuryginMG, ShuryginaIA, DreminaNN, KanyaOV (2013). Preconditioning as protection against ischemic myocardial injury [Prekonditsionirovanie kak zashchita ot ishemicheskogo povrezhdeniya miokarda]. Bulleten’ Vostocno-Sibirskogo naucnogo centra, 2-2 (90), 206-210</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШурыгинаИ.А., ШурыгинМ.Г., ЗеленинН.В., ГранинаГ.Б. Роль MAP-киназных механизмов в регуляции клеточного роста (обзор литературы) // Сибирский медицинский журнал. - 2009. - Т.89, No6.- С.36-40.</mixed-citation>
     <mixed-citation xml:lang="en">ShuryginaIA, ShuryginMG, ZeleninNV, GraninaLB (2009). Role of MAP -kinase mechanisms in the regulation of cell growth (literature review) [Rol’ MAP-kinaznykh mekhanizmov v regulyatsii kletochnogo rosta (obzor literatury)]. Sibirskiy meditsinskiy zhurnal, 89(6),    36-40.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">ArgaudL, Gateau-RoeschO, AugeulL, Cou-ture-LepetitE, LoufouatJ, GomezL, RobertD, OvizeM(2008). Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts. J Physiol Heart Circ Physiol,294(1), H386-391.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">FerdinandyP, HausenloyDJ, HeuschG, BaxterGF, SchulzR     (2014). Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev, 66(4), 1142-1174.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">Hernández-ReséndizS, ZazuetaC (2014). PHO-ERK1/2 interaction with mitochondria regulates the permeability transition pore in cardioprotective signaling. Life Sci, 108 (1), 13-21.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B21">
    <label>21.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">IliodromitisEK, AndreadouI, IliodromitisK,DagresN (2014). Ischemic and postischemic condition-ing of the myocardium in clinical practice: challenges, expectations and obstacles. Cardiology, 129 (2), 117-125.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B22">
    <label>22.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">KhanAR, BinabdulhakAA, AlastalY, KhanS,Faricy-BeredoBM, LuniFK, LeeWM, KhuderS, TinkelJ (2014). Cardioprotective role of ischemic postcondition-ing in acute myocardial infarction: a systematic review and meta-analysis. Am Heart J, 168(4), 512-521.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B23">
    <label>23.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">McFallsEO, KellyRF, HuQ, MansoorA, LeeJ,KuskowskiM, SikoraJ, WardHB, ZhangJ (2007). The energetic state within hibernating myocardium is normal during dobutamine despite inhibition of ATP-dependent potassium channel opening with glibenclamide. Am J Physiol Heart Circ Physiol, 293 (5), H2945-2951.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B24">
    <label>24.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">MurphyE, SteenbergenC (2008). Mechanisms underlying acute protection from cardiac ischemia-reper-fusion injury. Physiol Rev, 88(2), 581-609.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B25">
    <label>25.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">NajafiM, FarajniaS, MohammadiM, Badalza-dehR,    AhmadiAslN., BaradaranB, AmaniM (2014). Inhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in dia-betic hearts. J Diabetes Metab Disord, 13(1), 106.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B26">
    <label>26.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">Vinten-JohansenJ, ZhaoZQ, ZattaAJ, KinH, HalkosME, KerendiF (2005). Postconditioning - a new link in nature’s armor against myocardial ischemia-reper-fusion injury. Basic Res Cardiol, 100 (4), 295-310.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B27">
    <label>27.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">WuN, LiW, ShuW, LvY, JiaD (2014). Inhibition of Rho-kinase by fasudil restores the cardioprotection of ischemic postconditioning in hypercholesterolemic rat heart. Mol Med Rep, 10(5), 2517-2524.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B28">
    <label>28.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">ZangWJ, SunL, YuXJ (2007). Cardioprotec-tion of ischemic postconditioning and pharmacological post-treatment with adenosine or acetylcholine. Sheng Li Xue Bao, 59(5), 593-600.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B29">
    <label>29.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">ZhaoZQ, CorveraJS, HalkosME, KerendiF, WangN   P, GuytonRA, Vinten-JohansenJ (2003). Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am  J Physiol   Heart Circ Physiol, 285(2), H 579-588</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
